Perceive Biotherapeutics

South San Francisco, United States

Perceive Biotherapeutics is a biotechnology company pioneering novel technologies and therapeutics in ophthalmology.

Jan 2023

Series B

Biopharma Biotechnology Life Science Therapeutics

Top Investors

Catalio Capital ManagementDeerfieldJohnson & Johnson InnovationBraidwellRetinal Degeneration Fund

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Perceive Biotherapeutics

Who are Perceive Biotherapeutics's investors?

Perceive Biotherapeutics's investors include Catalio Capital Management, Deerfield, Johnson & Johnson Innovation, Braidwell, Retinal Degeneration Fund.

Where is Perceive Biotherapeutics headquartered?

Perceive Biotherapeutics is headquartered in South San Francisco, United States.

What does Perceive Biotherapeutics do?

Perceive Biotherapeutics is a biotechnology company pioneering novel technologies and therapeutics in ophthalmology.

What stage is Perceive Biotherapeutics at?

Perceive Biotherapeutics is at the Series B stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated January 5, 2023.

MLA

"Perceive Biotherapeutics — Funding & Investors." VCBacked, January 5, 2023, https://www.vcbacked.co/company/perceive-biotherapeutics. Accessed July 1, 2026.

APA

VCBacked. (2023). Perceive Biotherapeutics — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/perceive-biotherapeutics

Wikipedia (cite web)

{{cite web |title=Perceive Biotherapeutics — Funding & Investors |url=https://www.vcbacked.co/company/perceive-biotherapeutics |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated January 5, 2023.